News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,038 Results
Type
Article (54876)
Company Profile (243)
Press Release (573919)
Section
Business (174527)
Career Advice (2484)
Deals (32083)
Drug Delivery (121)
Drug Development (81158)
Employer Resources (152)
FDA (16739)
Job Trends (13705)
News (313994)
Policy (33960)
Tag
Academia (2662)
Alliances (45736)
Alzheimer's disease (1384)
Approvals (16671)
Artificial intelligence (158)
Bankruptcy (318)
Best Places to Work (10389)
Biotechnology (172)
Breast cancer (202)
Cancer (1495)
Cardiovascular disease (128)
Career advice (2080)
CAR-T (110)
Cell therapy (310)
Clinical research (64771)
Collaboration (539)
Compensation (295)
COVID-19 (2675)
C-suite (127)
Data (1420)
Diabetes (192)
Diagnostics (5621)
Drug pricing (111)
Earnings (65785)
Employer resources (139)
Events (92992)
Executive appointments (428)
FDA (17498)
Funding (474)
Gene therapy (229)
GLP-1 (723)
Government (4189)
Healthcare (16884)
Infectious disease (2774)
Inflammatory bowel disease (117)
Interviews (451)
IPO (15319)
Job creations (3731)
Job search strategy (1743)
Layoffs (482)
Legal (8084)
Lung cancer (227)
Manufacturing (231)
Medical device (11911)
Medtech (11915)
Mergers & acquisitions (16986)
Metabolic disorders (538)
Neuroscience (1753)
NextGen: Class of 2025 (5766)
Non-profit (4289)
Northern California (1753)
Obesity (312)
Opinion (246)
Patents (131)
People (51182)
Phase I (19875)
Phase II (28176)
Phase III (21718)
Pipeline (560)
Postmarket research (2916)
Preclinical (8479)
Radiopharmaceuticals (249)
Rare diseases (296)
Real estate (5236)
Regulatory (23309)
Research institute (2409)
Resumes & cover letters (408)
Southern California (1488)
Startups (3389)
United States (15424)
Vaccines (653)
Weight loss (245)
Date
Today (110)
Last 7 days (796)
Last 30 days (1997)
Last 365 days (34215)
2025 (891)
2024 (34749)
2023 (38974)
2022 (49766)
2021 (53530)
2020 (51067)
2019 (42164)
2018 (32110)
2017 (31980)
2016 (30679)
2015 (34508)
2014 (27586)
2013 (23027)
2012 (24681)
2011 (25421)
2010 (23665)
Location
Africa (836)
Arizona (156)
Asia (38858)
Australia (6646)
California (3910)
Canada (1349)
China (341)
Colorado (173)
Connecticut (202)
Europe (89153)
Florida (554)
Georgia (126)
Illinois (376)
Indiana (214)
Maryland (677)
Massachusetts (3077)
Michigan (154)
Minnesota (283)
New Jersey (1137)
New York (1094)
North Carolina (784)
Northern California (1753)
Ohio (139)
Pennsylvania (907)
South America (1188)
Southern California (1488)
Texas (560)
Washington State (405)
629,038 Results for "alzheimer s drug discovery foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
Cassava’s Shares Plunge as Alzheimer’s Drug Fails Phase III
Cassava Sciences has revealed the late-stage clinical failure of controversial Alzheimer’s drug simulfilam. The company had pledged to share the results whether “good, bad or ambiguous.”
November 25, 2024
·
2 min read
·
Annalee Armstrong
Deals
Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)
Coya Therapeutics, Inc. announces that the Alzheimer’s Drug Discovery Foundation (“ADDF”) has purchased 603,136 shares of the Company’s common stock at a purchase price of $8.29 per share for an aggregate investment of $5 million.
May 20, 2024
·
14 min read
Press Releases
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
January 8, 2025
·
5 min read
Alzheimer’s disease
Lilly Lowers Brain Swelling With Modified Dosing of Alzheimer’s Drug Kisunla
Approved by the FDA in July to treat adults with early symptomatic Alzheimer’s disease, Eli Lilly’s Kisunla reduced the brain swelling of patients in a late-stage trial following an adjusted dosing regimen.
October 30, 2024
·
2 min read
·
Tristan Manalac
BioMidwest
Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
Harrington Discovery Institute Center for Brain Health Medicines at University Hospitals and the Alzheimer’s Drug Discovery Foundation announce a joint request for proposals for the 2024 ADDF-Harrington Scholar Award.
April 1, 2024
·
4 min read
Podcast
BridgeBio’s ATTR-CM Approval, Cassava’s Alzheimer’s Failure, Trump’s Cabinet Picks, More
BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for Amvuttra in the indication; Cassava’s controversial Alzheimer’s drug flunks Phase III; Amgen’s MariTide fails to impress investors, Donald Trump’s controversial nominations continue.
November 27, 2024
·
1 min read
·
Heather McKenzie
Business
Filippo Berio announces exclusive partnership with Alzheimer’s Drug Discovery Foundation, supporting critical research and brain health
Filippo Berio, one of the nation’s top-selling and longstanding olive oil brands, has established an exclusive partnership with the Alzheimer’s Drug Discovery Foundation to raise awareness for Alzheimer’s disease and contribute crucial funds to support groundbreaking research aimed at finding a cure for Alzheimer’s and related dementias.
April 8, 2024
·
5 min read
GLP-1
Evidence Mounts for Potential of GLP-1s in Alzheimer’s Disease
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
December 9, 2024
·
6 min read
·
Heather McKenzie
Press Releases
New Investment from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Leads Efforts to Develop Standardization Materials for Leading Diagnostic Biomarker
November 15, 2024
·
5 min read
BioCapital
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer’s Prediction Biomarker
Brain diagnostics innovator BrainScope announced today a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B equity financing round.
September 19, 2023
·
4 min read
1 of 62,904
Next